Understanding idiopathic pulmonary fibrosis - Clinical features, molecular mechanism and therapies-Reference-Cited by-同舟云学术

Understanding idiopathic pulmonary fibrosis - Clinical features, molecular mechanism and therapies

Published:2021-10 Issue: Volume:153 Page:111473
ISSN:0531-5565
Container-title:Experimental Gerontology
language:en
Short-container-title:Experimental Gerontology

Author:

Suri Gurparsad Singh,Kaur Gurleen,Jha Chandan Kumar,Tiwari Manish

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Genetics,Molecular Biology,Aging,Biochemistry

Reference162 articles.

1. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis;Adams;Sci. Adv.,2020

2. Hyper-acetylation of histones is involved in increased expression of the chemokine monocyte chemoattractant protein-1 (MCP-1) in idiopathic pulmonary fibrosis (IPF);Akhtar,2012

3. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis;Alder;Chest,2015

4. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study;Allen;Lancet Respir. Med.,2017

5. Telomerase mutations in families with idiopathic pulmonary fibrosis;Armanios;N. Engl. J. Med.,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effects of Saorilao-4 on the gut microbiota of pulmonary fibrosis model rats based on 16S rRNA sequencing;Journal of Applied Microbiology;2024-07

2. Platelet Activating Factor Receptor and Intercellular Adhesion Molecule–1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis;Journal of Clinical Medicine;2024-04-06

3. Genetic and Pharmacological Inhibition of PAPP-A Reduces Bleomycin-Induced Pulmonary Fibrosis in Aged Mice via Reduced IGF Signaling;Aging Biology;2024-02-13

4. Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective Autotaxin inhibitor, in healthy subjects: A phase I randomized placebo-controlled trial;European Journal of Pharmaceutical Sciences;2023-10

5. Pachymic acid ameliorates bleomycin‐induced pulmonary fibrosis through inhibiting endoplasmic reticulum stress in rats;Environmental Toxicology;2023-05-10